🇺🇸 FDA
Patent

US 8785640

Modulators of cystic fibrosis transmembrane conductance regulator

granted A61KA61K31/4709A61K45/06

Quick answer

US patent 8785640 (Modulators of cystic fibrosis transmembrane conductance regulator) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K31/4709, A61K45/06, A61P, A61P1/10